These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15363482)

  • 21. Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative.
    Marder SR; Fenton W; Youens K
    Am J Psychiatry; 2004 Jan; 161(1):25. PubMed ID: 14702244
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300.
    Higuchi Y; Sumiyoshi T; Kawasaki Y; Matsui M; Arai H; Kurachi M
    Schizophr Res; 2008 Apr; 101(1-3):320-30. PubMed ID: 18321680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
    Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
    Hum Psychopharmacol; 2007 Oct; 22(7):445-54. PubMed ID: 17691076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia.
    Wang CH; Li Y; Yang J; Su LY; Geng YG; Li H; Wang JK; Mu JL
    Schizophr Res; 2013 Mar; 144(1-3):129-35. PubMed ID: 23352776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment in error monitoring predicts poor executive function in schizophrenia patients.
    Silver H; Goodman C
    Schizophr Res; 2007 Aug; 94(1-3):156-63. PubMed ID: 17561375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
    Maina G; Albert U; Rosso G; Bogetto F
    J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
    Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
    Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting cognition in schizophrenia research: from etiology to treatment.
    Goldberg TE; Gomar JJ
    Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient outcomes in schizophrenia II: the impact of cognition.
    Hofer A; Baumgartner S; Bodner T; Edlinger M; Hummer M; Kemmler G; Rettenbacher MA; Fleischhacker WW
    Eur Psychiatry; 2005 Aug; 20(5-6):395-402. PubMed ID: 16171654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
    Suzuki H; Gen K; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):161-8. PubMed ID: 21047544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MATRICS initiative: developing a consensus cognitive battery for clinical trials.
    Green MF; Nuechterlein KH
    Schizophr Res; 2004 Dec; 72(1):1-3. PubMed ID: 15531401
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia.
    Vita A; Deste G; De Peri L; Barlati S; Poli R; Cesana BM; Sacchetti E
    Schizophr Res; 2013 Oct; 150(1):51-7. PubMed ID: 23998953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
    Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
    Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive dysfunction in schizophrenia.
    Lublin H
    Acta Psychiatr Scand Suppl; 2001; (408):5-9. PubMed ID: 11730073
    [No Abstract]   [Full Text] [Related]  

  • 39. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.
    Voruganti LP; Awad AG; Parker G; Forrest C; Usmani Y; Fernando ML; Senthilal S
    Schizophr Res; 2007 Nov; 96(1-3):146-55. PubMed ID: 17728106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
    Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.